Abstract. We describe two male pubertal cases of constitutionally tall stature (CTS) with an enlarged pituitary gland or pituitary microadenoma. Both patients' basal serum growth hormone (GH) levels were normal. Neither had oversecretion of any other pituitary hormones. However, their serum GH levels were paradoxically increased in response to an intravenous administration of thyrotropin-releasing hormone (TRH). A later GH response to an intravenous administration of luteinizing hormone-releasing hormone (LHRH) was also found in one patient. In addition, oral glucose loading (OGL) caused a late increase in serum GH at 180 min in both patients. Our present findings suggest that endocrinological and morphological abnormalities of the pituitary gland are found in some subjects with CTS during puberty. It is speculated that these paradoxical GH responses are associated with dysregulation of GH secretion. Finally, it is important to investigate whether tall children with morphological abnormalities of the pituitary gland such as our patients are preacromegalic, in which case, given that overproduction of GH secretion may occur in the future, further observation is necessary.
THE clinical management of unusually tall children during puberty is difficult because of the effect of puberty on endocrinological responses. Recent reports have suggested that some children and adolescents with constitutionally tall stature (CTS) have a disorder of the hypothalamo-pituitary regulation of GH secretion that is seen in acromegaly [1] [2] [3] [4] [5] . Therefore, it is important to investigate whether these patients are preacromegalic. We recently experienced two male pubertal cases of CTS with morphological abnormality of the pituitary gland. In the present paper, we report the endocrinological and radiological findings in these two cases.
Case Reports

Case 1
A 12-year-old boy was admitted to our hospital because of tall stature. He was born by normal delivery after a 40-week pregnancy. At birth, his body length was 51.0 cm (+78SD) and his body weight was 3328 g (+0.32SD). At the age of one year, his tall stature (86.0 cm, +4.78SD) was noted. The height of the father is 172 cm and that of the mother 176 cm. When this patient first visited our outpatient clinic, his blood test revealed a high GH concentration (29.3 ng/ml). His recent growth velocity was 9.0 cm/year (Fig. 1) .
On admission, he had a body temperature of 36.6°C, and blood pressure of 120/64 mmHg. His height and weight were 182.0 cm (+4.5SD) and 51.0 kg (body mass index: 15.4 kg/m 2 ), respectively. Bone age was 12.8 years by the Tanner-Whitehouse (TW2) method standardized for Japanese children. The development of his external genitalia and pubic hair was Tanner stage III. Testicular volume was 10 ml. Heel pad thickness was 19 mm.
Laboratory findings showed serum levels of GH, IGF-I, and IGFBP-3 of 0.33 ng/ml, 460 ng/ml, and 3.55 mg/ml, respectively (Table 1) . Mean urine GH concentration for three consecutive days was 32.6 pg/mgCr. On endocrinological examinations, GH responses to growth hormone-releasing hormone (GHRH) (0.83 ® 27.5 ng/ml) and insulin (0.5 ® 34.2 ng/ml) were within normal limits. Moreover, oral glucose loading (OGL) suppressed serum GH levels (0.41 ® 0.25 ng/ml) during 120 min, but caused a late increase (22.2 ng/ml) at 180 min (Table 2) . On LHRH test, normal pubertal responses of LH and FSH were found. TRH test revealed normal responses of TSH and PRL. However, serum GH levels were paradoxically increased in response to TRH (Table 2) . No paradoxical GH response to LHRH was found. Brain magnetic resonance imaging (MRI) showed a slightly enlarged pituitary gland (Fig. 2) . The height of the pituitary gland was 10 mm. Its consistency was homogeneous, and no pituitary adenoma was detected.
In view of these findings, this case was diagnosed as CTS with a slightly enlarged pituitary gland. Since discharge, the patient has been observed without treatment at regular intervals. His final height is predicted to be 189.5 cm by the TW2 method standardized for Japanese children, whereas his target height is 180.5 cm.
Case 2
A 14-year-old boy was referred to our outpatient clinic because of tall stature. He was born by normal delivery after a 39-week pregnancy. At birth, his body length was 55.0 cm (+2.86SD) and his body weight was 3550 g (+0.88SD). The height of the father is 174 cm and that of the mother 171 cm. He was admitted to our hospital for endocrinological evaluation because his height SDS had always been more than +3SD (Fig. 1) .
On admission, he had a body temperature of 36.7°C, and blood pressure of 128/60 mmHg. His height and weight were 185.5 cm (+3.2SD) and 56.9 kg (body mass index: 16.5 kg/m 2 ), respectively. Bone age was 14.5 years by the TW2 method standardized for Japanese children. The development of his external genitalia and pubic hair was Tanner stage IV. Testicular volume was 12 ml. Heel pad thickness was 17 mm. Laboratory findings showed serum levels of GH, IGF-I and IGFBP-3 of 0.43 ng/ml, 470 ng/ml, and 3.24 mg/ml, respectively (Table 1) . Mean urine GH concentration for three consecutive days was 15.3 pg/ mgCr. On endocrinological examinations, GH responses ormal ranges of LH and FSH are those for the pubertal age group. M; male. to insulin (0.32 ® 28.0 ng/ml) and bromocriptine (1.25 ® 38.1 ng/ml) were within normal limits. OGL suppressed serum GH levels (1.17 ® 0.22 ng/ml) during 120 min, but caused a late increase (34.2 ng/ml) at 180 min, as in case 1 (Table 3) . On LHRH test, pubertal responses of LH and FSH were found. TRH test revealed mild TSH deficiency and normal response of PRL. In addition, paradoxical GH responses to both TRH and LHRH were found in this patient (Table 3) . On dynamic MRI of the brain, the size of the pituitary gland was normal (Fig. 3A) . However, a less enhanced lesion suggestive of microadenoma was (Fig. 3B) . Based on these findings, case 2 was diagnosed as CTS with non-functioning pituitary microadenoma. He too is being observed without treatment. On a recent MRI of his brain, the less enhanced lesion was still seen in the anterior pituitary gland. His final height is predicted to be 194.6 cm by the TW2 method standardized for Japanese children, whereas his target height is 179.0 cm.
Discussion
It is well-known that endocrinological abnormalities such as elevated GH levels, paradoxical increase in GH to an oral glucose loading (OGL) [6] , and GH release in response to exogenous TRH [7] are found in patients with acromegaly or pituitary gigantism.
Furthermore, paradoxical effects of TRH administration have also been reported in some constitutionally tall children during puberty and adolescence [1] [2] [3] . The findings suggest that pituitary somatotrophic cells may be more sensitive to TRH in the presence of high levels of sex hormone [8] . Other data revealed that about two-thirds of the cases of CTS in late puberty may have paradoxical GH release in response to OGL [9, 10] . Hindmarsh et al. reported in 1986 that abnormalities of pituitary morphology as well as endocrinological abnormalities might occur in tall children during puberty [11] . They studied GH secretory dynamics in 38 (25 girls and 13 boys) tall children (range of height SDS: +1.8 to +4.9) in puberty. Four of these children had abnormal GH response to exogenous TRH, and two other children had paradoxical GH responses to OGL. Additionally, pituitary radiology revealed morphological abnormalities suggestive of Less enhanced lesion suggestive of microadenoma was detected in the anterior pituitary gland.
microadenoma in 17 of these 38 children. However, none of the children in the Hindmarsh studies progressed to become a pituitary gigantism or acromegaly over a mean follow-up of 3.2 years. In conclusion, they pointed out that abnormal endocrinology and radiology are seen in some tall children during puberty. In our two patients, paradoxical GH release was observed in response to exogenous TRH. In one of these patients, later GH increase in response to exogenous LHRH was also found. OGL caused a late increase in serum GH in both patients. On radiological study, brain MRI revealed an enlarged pituitary gland in one patient and pituitary microadenoma in the other. These findings suggest that paradoxical GH responses on TRH, LHRH or OGL tests could be associated with CTS with morphological abnormalities of the pituitary gland. Similar findings in preacromegalic patients were reported by Evain-Brion et al. [1] . Therefore, GH secretion in children and adolescents with CTS should be investigated if abnormalities of pituitary morphology are detected on brain MRI. However, the correlation between these abnormal endocrinological and morphological findings is unclear.
It is difficult to differentiate a paradoxical GH release from a spontaneous GH surge when evaluating the result of the OGL test in cases of CTS during puberty. Evain-Brion et al. reported that a GH rise during the third hour after glucose loading is possibly abnormal [1] . Actually, 24 hour GH profiles will be required to explain whether the late GH increase at 180 min in our patients is dependent upon spontaneous GH secretion. With regard to paradoxical GH response to TRH or OGL, a previous study demonstrated the association with overproduction or dysregulation of GH secretion [1] . Further studies on TRH in cases of CTS have also suggested various possibilities: decrease of somatostatin release at the pituitary level, direct effect at the hypothalamic level, or alternation of pituitary cell receptors [2, 8, 12] . On the other hand, the mechanism by which LHRH may act upon GH secretion or release remains unknown. Further investigation is necessary.
Recently, increased IGF-II and IGFs (IGF-I and -II)/ IGFBPs (-1 + -2 + -3) molar ratio have been shown in prepubertal constitutionally tall children by Garrone et al. [13] . In their study, IGF-II/IGFBP ratio was responsible for the excess of the IGF peptide in relation to the concentrations of IGFBPs and for the increase in the potentially bioactive free form of the IGFs. They speculated that a greater availability of free IGF for target tissues such as cartilage and bone may be responsible for overgrowth in CTS. To clarify the cause of overgrowth in CTS, therefore, evaluations of IGF-II and IGFs/IGFBPs molar ratio in our two patients are underway.
Finally, treatment of CTS is generally of a psychological nature [14] . From a strict medical point of view, there is no reason for treatment. However, treatment to limit final height using bromocriptine or sex steroids may be beneficial if the predicted adult height is excessive compared with the target height [11, 14] . In addition, if overproduction of GH release becomes apparent in a subject with pituitary microadenoma, he or she may have to undergo surgery. Regular clinical, endocrinological, and radiological examinations at least once a year are considered useful, given that the outlook for preacromegalic patients without treatment is poor [15] . Although our two cases are now being followed up without treatment, long-term observation is intended.
